| 84,78 Euro | +0,797 +0,95 % | ||
| WKN: 920657 ISIN: FR0000120578 Ticker-Symbol: SNW | Frankfurt | 21.05.13 | 18:40 Uhr |
Branche PharmaAktienmarkt CAC-40EURONEXT-100 EURO STOXX 50 STOXX Europe 50 |
|
|
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 21.05. | UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer | |
Mehr lesen zu: UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer | ||
| 21.05. | Bullish Moving Average Cross by Sanofi-Aventis | |
Mehr lesen zu: Bullish Moving Average Cross by Sanofi-Aventis | ||
| 21.05. | Regeneron-Sanofi Asthma Drug Shows Promising Early Results | |
Mehr lesen zu: Regeneron-Sanofi Asthma Drug Shows Promising Early Results | ||
| 21.05. | Regeneron, Sanofi asthma drug seen as potential game changer | |
Mehr lesen zu: Regeneron, Sanofi asthma drug seen as potential game changer | ||
| 21.05. | Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In Asthma | |
| PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) and Regeneron Pharmaceuticals Inc.
(REGN) announced the publication of positive Phase 2a study results of dupilumab
in patients with moderate-to-severe... Mehr lesen zu: Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In Asthma |
